NEW YORK (AP) - Pfizer said Friday that its drug Torisel failed to help patients with a form of advanced kidney cancer when combined with Roche's drug Avastin.
The study compared renal cell carcinoma patients taking the Torisel-Avastin combination to those taking Avastin plus another cancer drug.
Patients taking the Pfizer combination did not show slower disease progression than those in the other group. Pfizer said.
Torisel is already approved as a stand-alone treatment for advanced renal cell carcinoma.
Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Weather models are lining up better and better, so the Forecast 8 team is confident enough to start putting snow projections for the winter weather through Friday night.
The City County Council is looking to change the law regarding your smoke detectors.
General Motors Corp. is spending $11 million at its Fort Wayne Assembly Plant to create a small power plant to supply 40 percent of the factory's operations.